PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29735362-2	2018	In this study, we tested whether an albumin-binding intravascular contrast agent (gadofosveset) allows for improved quantification of myocardial permeability compared to the conventional extracellular contrast agent Gd-DTPA using late gadolinium enhancement (LGE) and T1 mapping in vivo.	Gadolinium	235-245	albumin	Mus musculus	36-43	
34007253-10	2021	In addition, a strong visual colocalization of albumin-positive areas in the fluorescence albumin staining with gadolinium distribution in LA-ICP-MS was shown.	Gadolinium	112-122	albumin	Mus musculus	47-54	
34007253-10	2021	In addition, a strong visual colocalization of albumin-positive areas in the fluorescence albumin staining with gadolinium distribution in LA-ICP-MS was shown.	Gadolinium	112-122	albumin	Mus musculus	90-97	
27097822-1	2016	A macromolecular magnetic resonance imaging (MRI) contrast agent was successfully synthesized by conjugating the gadolinium/1,4,7,10-tetraazacyclododecane-1,4,7-tetracetic acid complex (Gd-DO3A) with 6,6-phenyl-C61 butyric acid (PC61BA) and upon further modification with human serum albumin (HSA).	Gadolinium	113-123	albumin	Mus musculus	284-291	
23700643-0	2004	Transferrin-coated gadolinium-labeled human serum albumin nanoparticles It is necessary to use small molecule contrast agents (CAs) to generate a good contrast in images produced with magnetic resonance imaging (MRI) for the proper diagnosis and monitoring of diseases.	Gadolinium	19-29	albumin	Mus musculus	44-57	
24123370-2	2014	Gadofosveset is a US FDA approved small molecule Gadolinium (Gd) chelate (957 Da) which reversibly binds serum albumin and temporally behaves as a macromolecule.	Gadolinium	49-59	albumin	Mus musculus	105-118	
24123370-2	2014	Gadofosveset is a US FDA approved small molecule Gadolinium (Gd) chelate (957 Da) which reversibly binds serum albumin and temporally behaves as a macromolecule.	Gadolinium	61-63	albumin	Mus musculus	105-118